Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial

BACKGROUND: Systemic morphine has evidence to support its use for reducing breathlessness in patients with severe chronic obstructive pulmonary disease (COPD). The effectiveness of the nebulized route, however, has not yet been confirmed. Recent studies have shown that opioid receptors are localized...

Descripción completa

Detalles Bibliográficos
Autores principales: Janowiak, Piotr, Krajnik, Małgorzata, Podolec, Zygmunt, Bandurski, Tomasz, Damps-Konstańska, Iwona, Sobański, Piotr, Currow, David C., Jassem, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725796/
https://www.ncbi.nlm.nih.gov/pubmed/29228935
http://dx.doi.org/10.1186/s12890-017-0535-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725796/
https://www.ncbi.nlm.nih.gov/pubmed/29228935
http://dx.doi.org/10.1186/s12890-017-0535-y

Ejemplares similares